Head and neck cancer patients have varied risks for second malignancies
MD Anderson-led research published in the journal Cancer is shedding light on the risk of second primary malignancies, a leading cause of long-term mortality in patients diagnosed with head and neck cancers.
The study, led by Erich M. Sturgis, M.D., professor in the Department of Head and Neck Surgery, sought to determine the impact of secondary primary cancers in relation to the original cancer site and explore potential factors...
Joining a clinical trial to prevent breast cancer recurrence
I finished the most active treatment phase for male breast cancer in the first week of June, enjoyed a few weeks off...
Brain tumor thrives when its immature cells are safe from growing up
In glioblastoma multiforme (GBM), the most common and lethal brain tumor, lack of differentiation makes a big, and bad...
First targeted drug may end cancer-promoting Skp2's days of dodging bullets
A protein called Skp2, overexpressed in many types of cancer, for years has gotten away with promoting tumor growth and progression unhindered by effective treatments.
Hui-Kuan Lin, Ph.D., of Molecular and Cellular Oncology, has spent the last decade characterizing Skp2 and how it fuels cancer growth, and the past five years looking for a way to shut it down.
Lin teamed with Shuxing Zhang, M.D., Ph.D., in Experimental Therapeutics...